Delivery Order SPE2DB24D1021-SPE2DB25FEXNU

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,147.94, is for the supply of JANUMET XR 50-1,000 mg tablets over a period ending on April 1, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,354.69, is for the delivery of Janumet XR 50-1,000 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 MG TABLET 180S. The contract has a ceiling value of $3,323.50 and a period of performance through May 30, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,045.52, is for the delivery of Janumet XR 50-1,000 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 MG TABLET 60S. The $9,327.88 firm fixed price contract has a completion date of June 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 MG tablets. The firm-fixed-price contract has a ceiling value of $19,786.80 and a performance period through August 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) the vendor holds with DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 MG TABLET 180S. The contract has a firm fixed price of $16,054.52 and a completion date of September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities from...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,660.94 firm-fixed-price contract is for the supply of Janumet 50-1,000 mg tablets. The contract has an ultimate completion date of May 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet XR 50-1,000 mg tablets. The $75,737.05 firm fixed price contract has a completion date of September 8, 2023 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of JANUMET XR 100-1,000 mg tablets. The contract has a ceiling value of $8,850.86 and is a firm fixed-price delivery order with a period of performance through September 30, 2024. The contract does not have any set-aside designations. As a supplier of pharmaceutical and medical products to numerous federal agencies and healthcare...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEXNU
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide JANUMET XR 50-1,000 MG TABLET 60S. The contract has a firm fixed price of $1,990.05 and a completion date of June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not set aside and represents open competition.

Generated 9/14/25, 1:05 AM